NL-OMON24855尚未招募不适用
An open-label randomised cross-over study to evaluate the albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes
niversity Medical Center Groningen (UMCG)0 个研究点目标入组 17 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Type 2 diabetes
- •HbA1c ≥ 7.5% (58 mmol/mol) and <10% (86 mmol/mol)
排除标准
- •Pregnant women and women of child-bearing potential who are not using
- •reliable contraception
研究者
相似试验
已完成
3 期
An open-label randomised cross-over study to evaluate the albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes10012653Diabetes MellitusdiabetesNL-OMON46820Martini Ziekenhuis20
进行中（未招募）
1 期
Study to evaluate the effect of dapagliflozin, exenatide and their combination on the loss of protein in urine in patients with type 2 diabetesEUCTR2017-004709-42-NLMartini Hospital17
已完成
不适用
An open-label, randomized crossover study to evaluate the pharmacokinetics, bioavailability, bioequivalence, and food effect following administration of Oxybate Formulations in healthy subjects.NL-OMON41817Jazz Pharmaceuticals60
已完成
不适用
An open-label, randomized crossover study to evaluate the effect of ASP1941 on the pharmacokinetics, pharmacodynamics, safety and tolerability of glimepiride in healthy subjects and vice versa.NL-OMON34715Astellas Pharma26
已完成
不适用
A randomized, open-label, crossover study to evaluate ICS/LABA treatment versus LAMA/LABA treatment in COPD with eosinophilic inflammatioCOPDJPRN-UMIN000024905Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital25